Month: August 2020

Spotlight on: The PATHOS Study

Posted on 5 August 2020 by Richard Haggerty

PATHOS is a Phase III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer. The aim of the study is to tailor treatment for participants with HPV-positive oropharyngeal cancer to reduce side-effects, particularly swallowing problems, which have a major impact on quality of life. We are
Read more